Atlas Trials

Hypophosphatasia (HPP)

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hypophosphatasia (HPP)

RecordFirmDate
A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1 (NCT07179640)Alesta Therapeutics2025-09-30
Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP) (NCT04181164)Hvidovre University Hospital2019-10-01
Registry of Patients With Hypophosphatasia (NCT02306720)Alexion Pharmaceuticals, Inc.2015-01-20
Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP) (NCT02104219)Alexion Pharmaceuticals, Inc.2014-03-01
A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP) (NCT01419028)Alexion Pharmaceuticals, Inc.2012-08-01
Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP) (NCT01203826)Alexion Pharmaceuticals, Inc.2010-04-01
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP) (NCT00952484)Alexion Pharmaceuticals, Inc.2009-09-01
Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP) (NCT00744042)Alexion Pharmaceuticals, Inc.2008-09-01
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP) (NCT00739505)Alexion Pharmaceuticals, Inc.2008-08-01

Track Hypophosphatasia (HPP) automatically

Every clearance here is in the API, with alerts when new ones post.